| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Urea cycle and related diseases 0.8957253886010359 3.644980093178115 0.0002674124998809 0.1462030886844526 0.0052680262476544 2 Q9Y619 1 |
| Estrogen receptor pathway 0.9502350201237056 3.5533260547101806 0.0003803926695391 0.2013678577973821 0.0066121196381658 3 Q9HCL2 1 |
| Serotonin and anxiety 0.8578367875647664 3.471569109637613 0.0005174261276599 0.2635235233045861 0.008264833552622 2 P05771 1 |
| Caloric restriction and aging 0.8757679949023202 3.2300092236629427 0.0012378622450492 0.5190681757053011 0.0144191565888401 3 P43490 1 |
| Type ii diabetes mellitus 0.8754339294698226 3.228527556735344 0.0012442927005598 0.5208947025234804 0.0144191565888401 3 O00330 1 |
| Congenital generalized lipodystrophy cgl 0.7840025906735744 3.121831524803229 0.0017972975950162 0.6546367686379718 0.0180029353082559 2 P31751 1 |
| Oligodendrocyte specification and differentiation leading to myelin components for cns 0.7700777202072531 3.054023093013877 0.0022579469918102 0.7370931517600618 0.0205299488024594 2 P09543 1 |
| Proteasome degradation 0.6673152725163428 3.0173993631418727 0.0025495368017465 0.7788027212421358 0.0228299431792756 39 P28074,P20618,P51665,P28070,Q99436,P49721,P28072,P60900,O75832 9 |
| Regulation of wnt bcatenin signaling by small molecule compounds 0.7551813471502582 2.9808053091306386 0.002874915030508 0.8175942763165657 0.02462427221783 2 P48729 1 |
| Signal transduction through il1r 0.7451424870466312 2.931060982760368 0.0033780646090577 0.8646397914534595 0.0281188194922977 2 Q9BQ95 1 |
| Cytosine methylation 0.9087093969431848 2.8242795704912784 0.004738703103009 0.9396280155038724 0.0368496517615572 5 P48735 1 |
| Type i interferon induction and signaling during sarscov2 infection 0.7679433996973739 2.736216127128427 0.0062150191935261 0.9748912271394846 0.044793613943585 3 Q7Z434 1 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.892317783762788 2.712937782904774 0.0066689626522882 0.980832862081516 0.0458297317151435 11 Q96AY3,O75718,Q32P28 3 |
| Unfolded protein response 0.814288645986273 2.66279420581636 0.0077494792215031 0.9899258296463298 0.0497819806511778 4 Q13794 1 |
| Hedgehog signaling pathway wp4249 0.8100816829898101 2.644057613056125 0.0081918711469695 0.992259855016812 0.0503179274122507 4 P48729 1 |
| Insulin signaling in adipocytes normal condition 0.8079146348790698 2.634388776950077 0.0084288913939303 0.9932794661886148 0.0503179274122507 4 P31751 1 |
| Insulin signaling in adipocytes diabetic condition 0.8079146348790698 2.634388776950077 0.0084288913939303 0.9932794661886148 0.0503179274122507 4 P31751 1 |
| Pi3kaktmtor vitd3 signaling 0.7998893827583423 2.598478505990019 0.0093637907059211 0.996151503796302 0.0553400030719942 4 P42345 1 |
| Hostpathogen interaction of human coronaviruses autophagy 0.7308066083576441 2.558541282530118 0.0105112338989934 0.9980599052411868 0.0609033258265208 3 Q99570,P42345 2 |
| Mecp2 and associated rett syndrome 0.6754480253252556 2.397414878002291 0.0165112168319905 0.999946700644755 0.0826960097263254 20 Q00013,P52597,P42345,P67809,Q05086,Q13451,P35637 7 |
| Tlr4 signaling and tolerance 0.6954972465176564 2.3858076543237687 0.0170416615961654 0.9999612518760868 0.0846354790196118 3 Q15750,Q13546 2 |
| Familial hyperlipidemia type 4 0.7434444892428607 2.3412414123258936 0.0192197348863949 0.9999895555478248 0.0878521505460166 4 Q9UBV2 1 |
| Nocgmppkg mediated neuroprotection 0.6817186339636179 2.317381905184381 0.0204829371512669 0.9999951236446843 0.0890104107088143 3 P07196 1 |
| Nanoparticle triggered autophagic cell death 0.6805960479429972 2.3117816743904025 0.0207897178020366 0.9999959477578028 0.0896841111022164 3 Q9NT62,Q9Y371 2 |
| Hostpathogen interaction of human coronaviruses interferon induction 0.722177483256705 2.2421793367765623 0.0249497840623336 0.9999996726993662 0.100995358772871 4 Q7Z434,P19525 2 |
| Glutathione metabolism 0.8196789516634295 2.2268065007404543 0.0259602087453518 0.9999998226508652 0.1042342294103925 6 P48506,O75874 2 |
| Mrna processing 0.4090173611668886 2.175350116805839 0.0296038895736769 0.9999999806408252 0.114352279333615 106 O75533,P61978,Q9BWJ5,Q16629,Q8IWZ8,O43791,Q9UKA9,P38159,Q99729,P52298,P09651,Q92879,P22626,O43390,Q14562,P31943,P62995,P23246,Q15287,P35637,P55795,Q14103,P67809 23 |
| 15q112 copy number variation syndrome 0.7067652316081527 2.169653885920517 0.030033075916539 0.9999999850946318 0.1152568043290556 4 Q06787,Q7L576 2 |
| Nitric oxide metabolism in cystic fibrosis 0.7044718081658998 2.1588090820428474 0.0308649816061916 0.99999999102337 0.117685187930705 4 O14744,Q86X55,Q99873 3 |
| Pi3kaktmtor signaling pathway and therapeutic opportunities 0.6386083308306583 2.099573268746586 0.0357663962993297 0.9999999995515468 0.1328984671274864 3 P42345 1 |
| Dna mismatch repair 0.6335204511950747 2.085005930534209 0.0370687622099623 0.9999999997982526 0.1335831613785838 19 P41440,P49005,Q9UQ84 3 |
| Alzheimers disease and mirna effects 0.4487240399914957 2.057923203962043 0.0395975059140916 0.999999999957353 0.1407803042028147 72 Q96IX5,P42345,P28074,P20618,P48729,P05198,P25788,Q07866,P51665,P28070,Q99436,P31751,P49721,Q9UJX6,P28072,P60900 16 |
| Dna replication 0.5775490009560035 2.055527769084599 0.0398280563447848 0.9999999999629944 0.1407803042028147 29 P41440,Q9Y619 2 |
| Kisspeptinkisspeptin receptor system in the ovary 0.7299694887471642 2.0535551511755425 0.0400187666769422 0.9999999999670935 0.1407803042028147 5 P31751 1 |
| Erbb signaling pathway 0.7090686347265781 2.050547924126735 0.0403109921836799 0.9999999999725124 0.1409692093523955 13 P46108,P42345,P31751,O00459,P05771,P46109,Q13555 7 |
| Mitochondrial long chain fatty acid betaoxidation 0.675204218319591 2.035232724572631 0.0418274617693641 0.9999999999892046 0.1410569306786508 15 P23786,Q9BY49,O43772,Q16836 4 |
| Ptf1a related regulatory pathway 0.6247414013535977 2.028322220722453 0.0425273725373829 0.9999999999929906 0.1410569306786508 3 O00330 1 |
| Pregnane x receptor pathway 0.6766994865835344 2.026409612501742 0.0427228267199297 0.9999999999937872 0.1410569306786508 4 Q99615 1 |
| Tgfbeta receptor signaling in skeletal dysplasias 0.6725102438104521 2.006267544369751 0.0448277108196415 0.9999999999983084 0.1416747438203644 4 O60315 1 |
| Tgfbeta receptor signaling 0.6725102438104521 2.006267544369751 0.0448277108196415 0.9999999999983084 0.1416747438203644 4 O60315 1 |
| Phosphoinositides metabolism 0.7615348985232543 1.9800412701737795 0.0476988914964249 0.9999999999997145 0.1461209566268024 6 Q9C0I1,Q13614,Q8TBX8 3 |
| Complement system 0.7447510098893992 1.9776761296380037 0.0479652547979689 0.999999999999758 0.1461209566268024 10 P26885,P48729 2 |
| Alzheimers disease 0.4414850680451317 1.9719826459491216 0.0486115876333295 0.999999999999838 0.1473305040579371 71 P05198,P42345,P28074,P20618,P48729,P31751,P25788,Q07866,P51665,P28070,Q99436,P49721,Q9UJX6,P28072,P60900 15 |
| Translation factors 0.5361101830687462 1.8578797165247491 0.0631860974074163 1.0 0.1778237312751573 33 P55010,P05198,O75153,P23588,O15371,P11940,Q04637,P06730,O75822,P19525,P60228,P63241,Q14240,P24534 14 |
| 4hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression 0.6841750428312517 1.8445180373303456 0.0651076796058527 1.0 0.1823632163367723 5 P06730,P42345,Q96KB5 3 |
| Chemokine signaling pathway 0.6005222722048984 1.8333446305153176 0.0667513361735454 1.0 0.1852114538899782 18 P41240,P46108,P31751,O00459,P05771,P46109,P04899 7 |
| Synaptic signaling pathways associated with autism spectrum disorder 0.7165045140733166 1.8115975445985808 0.0700484046248814 1.0 0.1916602182097452 8 P31751,Q05086,P42345 3 |
| Lncrnamediated mechanisms of therapeutic resistance 0.5343264248704649 1.8064409458704984 0.07084949064346 1.0 0.1922689585675105 2 P04637 1 |
| Met in type 1 papillary renal cell carcinoma 0.6199137815372889 1.802553933911814 0.0714582971962027 1.0 0.1928395143513965 16 P46108,Q92733,P31751,O00459,P46109,O43815 6 |
| Cholesterol biosynthesis with skeletal dysplasias 0.7180995718507412 1.7914382372166175 0.0732229975135114 1.0 0.194470634019809 6 Q15392 1 |
| Extracellular vesiclemediated signaling in recipient cells 0.5793170941715211 1.7910028698681824 0.0732928344665584 1.0 0.194470634019809 3 P42345 1 |
| Novel intracellular components of rigilike receptor rlr pathway 0.7071872569702091 1.755444148501274 0.0791833661015917 1.0 0.2043170957750134 7 Q92841,Q7Z434,O00571,Q13526 4 |
| G protein signaling pathways 0.6446580462545407 1.726955298162638 0.0841756919764535 1.0 0.2107959066020511 13 P05771,P10644,O43823 3 |
| Dna damage response 0.5384545470468575 1.7032003513470046 0.0885305809577023 1.0 0.2176764923784664 22 Q13794,Q9BXW9,P14635,P41440 4 |
| Ketogenesis and ketolysis 0.6953366952364244 1.7025780826976349 0.088647054570405 1.0 0.2176764923784664 7 O43772,P53985 2 |
| Praderwilli and angelman syndrome 0.6977576706976423 1.7019493469348663 0.0887648640663458 1.0 0.2176764923784664 6 Q05086,Q7L576,P42771 3 |
| Disruption of postsynaptic signaling by cnv 0.6900487853676891 1.6678569282699116 0.0953441316946723 1.0 0.2281311005325966 6 Q06787,Q13555 2 |
| Microglia pathogen phagocytosis pathway 0.5998055735579978 1.6499719732975824 0.0989486684970568 1.0 0.2295608658474715 4 P63000,O00459,P07948 3 |
| Micrornas in cardiomyocyte hypertrophy 0.6448473502760784 1.6491622915898465 0.0991143908887397 1.0 0.2295608658474715 12 Q9P2K5,P42345,P31751,O00459,P05771,P50750,P35222 7 |
| Tryptophan metabolism 0.6124627527787303 1.644820315692738 0.1000068713442474 1.0 0.2295608658474715 14 Q16836 1 |
| Mirna regulation of dna damage response 0.5282288779854333 1.6438151637878105 0.1002143881364596 1.0 0.2295608658474715 23 Q13794,Q9BXW9,P14635,P41440 4 |
| Cohesin complex cornelia de lange syndrome 0.5664487206931361 1.63400267136026 0.1022582896802013 1.0 0.233338413903471 18 Q7Z5K2,P53350,P06493,P30153,Q8N3U4,P30154 6 |
| Metapathway biotransformation phase i and ii 0.5227717563862102 1.6013250020496406 0.109304954175915 1.0 0.2462286109721216 22 O43708,P28161,Q86UY6,P07099 4 |
| Bladder cancer 0.6283152479169303 1.5837749262058982 0.1132449471470458 1.0 0.2535142566814548 5 O00459,P42771 2 |
| Glycogen synthesis and degradation 0.6153709058175763 1.5769811586569926 0.1147998604710756 1.0 0.2559330649912711 13 P63151,P30154,P35573,P30153 4 |
| Tp53 network 0.5848573566622928 1.5752812853474574 0.1151915317896414 1.0 0.2559330649912711 4 Q13794 1 |
| Pi3kakt signaling pathway 0.4926565333827947 1.565055789908988 0.1175698285102202 1.0 0.2592677934684334 34 P14625,P30154,P42345,P06756,P23588,Q16822,P31751,O00459,P13807,P06730,P54646,P30153,P63151,P62993 14 |
| Tolllike receptor signaling pathway 0.6637138992627283 1.5604173984833856 0.1186612759474052 1.0 0.2596914827378134 7 P31751,O00459,Q15750,Q13546 4 |
| G1 to s cell cycle control 0.5126147348711433 1.5486763904092091 0.1214595321485147 1.0 0.2619802317509935 24 Q9UBD5,Q99640,Q9Y619,Q14181,Q07864,P42771,P14635,P06493 8 |
| Hippo signaling regulation pathways 0.5702819863808523 1.526439366863854 0.1269004798916468 1.0 0.2707515654005895 16 P05771,P10644,P42345,P04899 4 |
| Il9 signaling pathway 0.6569631555928898 1.5205260021716915 0.1283788287345584 1.0 0.2729204596479281 6 P50750,O00459 2 |
| Cardiac hypertrophic response 0.6548400054894369 1.5110207379575826 0.1307831673225972 1.0 0.2770353114252865 6 P31751,P42345 2 |
| Photodynamic therapyinduced hif1 survival signaling 0.5989345617163945 1.4921979990572325 0.1356472467694334 1.0 0.2833713516005626 13 P53985 1 |
| Nucleotidebinding oligomerization domain nod pathway 0.6497898199900146 1.488389292363446 0.1366482587723481 1.0 0.2843631018818934 6 P07900,Q96RT1,Q9Y2Z0,Q9P0J0 4 |
| Tnfrelated weak inducer of apoptosis tweak signaling pathway 0.6451667573505265 1.4676459220352285 0.1422004271687749 1.0 0.2948787805499858 6 P63000,P31751,P35222,Q13546 4 |
| Hijack of ubiquitination by sarscov2 0.5618896435800296 1.4597425425189312 0.1443608450633009 1.0 0.2958089644566276 4 Q13617,Q15369 2 |
| Pdgfrbeta pathway 0.6431718782724186 1.458687695873847 0.1446510841420734 1.0 0.2958089644566276 6 P05771,P62993 2 |
| Glioblastoma signaling pathways 0.5648905194064532 1.3909069304239694 0.1642536509648886 1.0 0.3246618987299304 14 P31751,O00459,P05771,P42771,P62993 5 |
| Chromosomal and microsatellite instability in colorectal cancer 0.5433065955857754 1.3746331672420478 0.1692452005403579 1.0 0.3327342882230221 16 Q13794,P31751,P48729 3 |
| Fatty acid betaoxidation 0.4880312556867501 1.3739292235697385 0.1694636561000502 1.0 0.3327342882230221 22 O43772,Q16836,P23786 3 |
| Factors and pathways affecting insulinlike growth factor igf1akt signaling 0.5805475313369142 1.3568277463300524 0.1748359491218358 1.0 0.3398948879309375 5 Q13418 1 |
| Neural crest cell migration during development 0.6176612947794193 1.3511030951102074 0.1766624101500109 1.0 0.3403147750473697 7 P31751 1 |
| Embryonic stem cell pluripotency pathways 0.6141457311841153 1.3442891035818452 0.1788549177561229 1.0 0.3425608272064316 8 P31751,O00459,P62993,P42345 4 |
| Nucleotide excision repair 0.4922762219558911 1.341725436742863 0.179685036267333 1.0 0.3425608272064316 21 P41440,P49005 2 |
| Egfr tyrosine kinase inhibitor resistance 0.568300663862765 1.3333375149339208 0.1824210678063103 1.0 0.3458090241289916 13 P42345,P31751,O00459,P05771,P62993 5 |
| Neural crest cell migration in cancer 0.6096148686157068 1.323331866898204 0.1857250387053031 1.0 0.3495652798561597 8 P31751 1 |
| Head and neck squamous cell carcinoma 0.5640398583149611 1.311185148492717 0.1897952186950904 1.0 0.3560919817422172 13 P42345,P31751,O00459,P42771,P06730,P54646,P35222,P11802 8 |
| Fragile x syndrome 0.4633698650707191 1.3089565724875023 0.1905490616499485 1.0 0.3563749855541759 32 P50570,P50416,P42345,P53985,P42771,Q04637,Q96F07,P10644,Q06787,P62993,Q7L576 11 |
| Riboflavin and coq disorders 0.5701555078842637 1.3071313384084864 0.1911681096236495 1.0 0.3564048983835232 5 Q8NFF5,Q8NI60 2 |
| Urea cycle and associated pathways 0.5597091635563184 1.288661995897353 0.1975156201509891 1.0 0.3659301928189171 13 Q9Y619,O75746 2 |
| Il2 signaling pathway 0.6046503659979097 1.2850127403022091 0.1987878320083989 1.0 0.3671362772405117 6 P46109 1 |
| Wnt signaling pathway and pluripotency 0.5345497552571161 1.2739218831186656 0.202691102163909 1.0 0.3731789451055148 15 P30154,P05771,P30153 3 |
| Il1 signaling pathway 0.5624396914693057 1.2701890903038524 0.20401728281882 1.0 0.3744540811985175 5 Q9BQ95,O00459 2 |
| Ampactivated protein kinase ampk signaling 0.5239896732532047 1.2655555925552768 0.2056722333036638 1.0 0.3763228788930814 16 P50416,P42345,P31751,P13807,P54646,P14635 6 |
| Omega3 omega6 fatty acid synthesis 0.597548809770689 1.252897097874416 0.2102431582023807 1.0 0.3834990941284166 6 Q15067 1 |
| Allograft rejection 0.5930170160940813 1.2464812823913525 0.2125877567356529 1.0 0.3862722623084113 8 Q9BY49 1 |
| Tcell receptor tcr signaling pathway 0.589369844964565 1.2395798840535877 0.215130824828047 1.0 0.3883379650984156 9 O00459,P46108,P46109 3 |
| Ranklrank signaling pathway 0.5888197479569954 1.2369988743970044 0.2160875005095075 1.0 0.3883379650984156 9 P42345,P31751,O00459,Q15750,P63000 5 |
| Transcription cofactors ski and skil protein partners 0.5179343548692728 1.236746064250795 0.216181371433805 1.0 0.3883379650984156 4 O14744,Q96ST3 2 |
| Cell cycle 0.409622591046888 1.2113055083843305 0.2257783384073235 1.0 0.4027705711308502 46 Q9UBD5,Q92769,Q9H1A4,Q99640,Q9Y619,P42771,Q9UJX3,P53350,P14635,P06493,Q9UJX6,Q8N3U4 12 |
| Oxysterols derived from cholesterol 0.5851530447501097 1.210048489579446 0.2262602869973642 1.0 0.4027705711308502 8 O14734 1 |
| Endometrial cancer 0.5688328237295027 1.2079050182719189 0.2270837990950687 1.0 0.4030225983939507 11 P62993,P31751,O00459,Q9UJX6,Q13418 5 |
| Male infertility 0.4853773698142197 1.1958678779802323 0.2317481221314379 1.0 0.4088451945662084 19 Q15165 1 |
| Regulation of actin cytoskeleton 0.4505464703405042 1.186432935248333 0.2354513715827435 1.0 0.4141421446589328 30 Q8TBX8,P46108,O00459,Q99570,Q96F07,Q9UJX6,P12814 7 |
| Il17 signaling pathway 0.4271373056994801 1.1806255552044531 0.2377515070118119 1.0 0.4147468194757864 2 P40763 1 |
| Tca cycle nutrient use and invasiveness of ovarian cancer 0.4271373056994801 1.1806255552044531 0.2377515070118119 1.0 0.4147468194757864 2 P40763 1 |
| Mirna regulation of prostate cancer signaling pathways 0.5778440426457778 1.1637464586061932 0.2445267757929849 1.0 0.4235174336991007 6 P62993,P35222,P42345 3 |
| Ovarian infertility 0.4619784889020725 1.156173312744763 0.2476102734496239 1.0 0.4266228057028433 3 Q8WXH0 1 |
| Dna repair pathways full network 0.3966513468946576 1.141421101231604 0.2536947277310397 1.0 0.4333340580608221 48 Q9BXW9,P49005,P41440,Q9UQ84 4 |
| Constitutive androstane receptor pathway 0.5701942182451888 1.1291512841123317 0.2588340203316566 1.0 0.4383120516218024 6 Q08426,Q99615 2 |
| Nsp1 from sarscov2 inhibits translation initiation in the host cell 0.5270834820456554 1.1190266471763128 0.2631287711022678 1.0 0.4435568793054855 13 O15371,P55010,O75822,P05198 4 |
| Matrix metalloproteinases 0.4158031088082882 1.1135332988200808 0.2654794553106223 1.0 0.4457339718425506 2 Q9UGU0 1 |
| Nonsmall cell lung cancer 0.5246977610421354 1.1066467311859316 0.2684466945760753 1.0 0.4481694816227697 13 P31751,O00459,P05771,P42771,P62993 5 |
| Nongenomic actions of 125 dihydroxyvitamin d3 0.5627582183166415 1.0999767331607502 0.2713422594856587 1.0 0.4505317999971566 7 P05771,Q15648 2 |
| Genes related to primary cilium development based on crispr 0.5593023522723399 1.0985982670213372 0.2719433339494834 1.0 0.4505317999971566 9 Q10713,Q7Z392,A0AVF1 3 |
| 1q211 copy number variation syndrome 0.5552163268591133 1.0895431922754275 0.2759144186654079 1.0 0.4530040915571365 10 Q16625,P54646,P55196,P35222,Q9NPH0 5 |
| Interleukin1 il1 structural pathway 0.4889954813473517 1.0894815681551495 0.2759415786134842 1.0 0.4530040915571365 4 P06730 1 |
| Hepatitis c and hepatocellular carcinoma 0.5559355386949576 1.0688246421380845 0.2851486933346963 1.0 0.4634787737383912 7 Q14247,P62993,P31350 3 |
| Il6 signaling pathway 0.5557846941018746 1.0681363571387883 0.2854590078524102 1.0 0.4634787737383912 7 P63000,O00459,P62993 3 |
| Cancer immunotherapy by pd1 blockade 0.4073834196891172 1.0637479482028516 0.2874428970364278 1.0 0.4641495960342318 2 P40763 1 |
| Osteoblast differentiation and related diseases 0.5485496148692479 1.057962134606647 0.2900727057275658 1.0 0.4658504594700853 10 O00459,Q99570,P05771 3 |
| Androgen receptor signaling pathway 0.4380513874697977 1.0556792400480193 0.2911147848473958 1.0 0.4662570131295689 25 Q02790 1 |
| Breast cancer pathway 0.4428521746082669 1.026049486043207 0.3048682588279776 1.0 0.4838670093522246 21 P42345,P48729,P31751,O00459,Q9UJX6,P11802,P62993 7 |
| H19 action rbe2f1 signaling and cdkbetacatenin activity 0.5094314438494988 1.01646049975755 0.3094101483040652 1.0 0.4876303937272068 5 Q13794,P11802,Q15648 3 |
| Mir124 predicted interactions with cell cycle and differentiation 0.3983160621761638 1.0102411400284907 0.3123797733942599 1.0 0.4901937800466719 2 Q13131 1 |
| Histone modifications 0.5371155843549548 1.0039335096512816 0.3154106633844138 1.0 0.4931420689422978 10 Q15047,Q9H7B4 2 |
| Tcell activation sarscov2 0.5385800685743384 0.9898101337998774 0.3222669306781669 1.0 0.5012098842915702 7 P42345,P42771 2 |
| Lipid metabolism pathway 0.5108081461575005 0.976760493631976 0.3286877386883908 1.0 0.5098542088315984 12 P31751,P10644 2 |
| Apoptosis modulation by hsp70 0.425979915775837 0.9596319799198972 0.3372404679935901 1.0 0.5190341577713847 3 O95831,Q13546 2 |
| Pancreatic adenocarcinoma pathway 0.4484225583839152 0.9338389636181816 0.3503869673586171 1.0 0.5368666301278823 18 P31751,O00459,P42345,P42771 4 |
| Circadian rhythm genes 0.3904005861184938 0.928004288848289 0.3534053448950622 1.0 0.5376511195664974 40 Q9NRV9,P50416,Q92769,Q9BWF3,Q96ST3,Q13131,P23246,Q14103,O14744,Q05086,P54646,P43490,P17844,P11802,Q8N163 15 |
| Mfap5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement 0.4906164506487372 0.9270791823820168 0.3538854238771023 1.0 0.5376511195664974 5 P12814 1 |
| Autophagy 0.5203922890236744 0.9075433171362528 0.3641195535517889 1.0 0.5517811696130955 7 Q9NT62,P54646,Q99570,P42345 4 |
| Amyotrophic lateral sclerosis als 0.5150103383268617 0.8870909023387099 0.3750299617310477 1.0 0.5668611442021719 8 P07196 1 |
| Physiological and pathological hypertrophy of the heart 0.5130650182442203 0.872739402697629 0.3828051355465538 1.0 0.5742077033198307 6 Q9P2K5,P05771 2 |
| Regulatory circuits of the stat3 signaling pathway 0.5089585116436218 0.8545557843793999 0.3927971144339053 1.0 0.5877040370390836 6 P05771 1 |
| Hepatocyte growth factor receptor signaling 0.5021068406909803 0.8287162686072702 0.4072649778292363 1.0 0.6017340047426967 8 P46108,P46109 2 |
| Wnt signaling pathway 0.498974823649319 0.8257797890985861 0.4089290210251337 1.0 0.6026859137801847 10 P05771,P48729 2 |
| Mitochondrial immune response to sarscov2 0.4983265913337067 0.816335512053821 0.4143082688658399 1.0 0.6086731511364676 9 Q7Z434,Q9Y6M9,Q9Y375 3 |
| Tcell antigen receptor tcr pathway during staphylococcus aureus infection 0.4997157614580855 0.8150368187947511 0.415051235038911 1.0 0.6086731511364676 7 P62993,Q99653 2 |
| Modulators of tcr signaling and t cell activation 0.4974443435496206 0.8123255618495604 0.4166048467380783 1.0 0.6094392683717927 9 Q12824,O00459,P62993 3 |
| Base excision repair 0.4261396307452209 0.8046497620502909 0.4210218176351861 1.0 0.6114868744980162 18 P49005,Q9NR33 2 |
| Melanoma 0.475140741003084 0.800920126307788 0.4231778877659706 1.0 0.6114868744980162 12 P31751,O00459,P62993,P42771 4 |
| Nonhomologous end joining 0.3958535795270551 0.7976125315933503 0.4250953765467504 1.0 0.6127594330222671 3 P12956,P78527 2 |
| Oncostatin m signaling pathway 0.4833809336246867 0.7948451962317191 0.426703556736216 1.0 0.6135810268396684 11 P05771 1 |
| Cytosolic dnasensing pathway 0.4913285926769986 0.7846142534710983 0.4326797705090592 1.0 0.6180388668764725 9 Q7Z434,O14802,O15160 3 |
| Envelope proteins and their potential roles in edmd physiopathology 0.4444810959104265 0.7837517246097888 0.4331858054732049 1.0 0.6180388668764725 15 Q8WXH0,Q14739,O94901,P50402 4 |
| Sarscov2 innate immunity evasion and cellspecific immune response 0.4871639188294199 0.7715895565919965 0.4403575615910986 1.0 0.6226108107663619 10 Q7Z434,P52948,Q92769 3 |
| Target of rapamycin tor signaling 0.4883172338120506 0.7669896692115101 0.4430876578108755 1.0 0.6249756700864617 8 P42345 1 |
| Integrinmediated cell adhesion 0.4120433564887802 0.7245855665191397 0.4687063162265543 1.0 0.6568709105343205 18 P41240,P46108,P06756,P31751,O00459,Q13418 6 |
| Apoptosis modulation and signaling 0.4494382575343109 0.7236375884053426 0.4692882585001285 1.0 0.6568709105343205 13 O43464,O95817,Q13794,Q9Y3E5,P42771 5 |
| Focal adhesion 0.3803380351569176 0.7093187968536594 0.4781266664014953 1.0 0.6648773172783148 31 P46108,Q14315,P06756,P31751,O00459,P05771,P46109,P12814,Q13418 9 |
| Hepatitis b infection 0.3963005021518879 0.6993254697517531 0.4843486533271477 1.0 0.6703748339961224 20 Q7Z434,O00571,P05771,P31751,Q15904 5 |
| Regulation of sister chromatid separation at the metaphaseanaphase transition 0.4701766891742778 0.6857091488275395 0.4928965363821005 1.0 0.6790252983725441 7 Q9UJX6 1 |
| Il4 signaling pathway 0.4679276642367114 0.6763149601583831 0.4988406964586382 1.0 0.6840251777425875 6 O00459 1 |
| Mitochondrial complex i assembly model oxphos system 0.3713623834625726 0.6498438342096757 0.5157931011988643 1.0 0.7007671788701813 31 P03886,Q9Y6M9,O95182,Q9Y375,P51970,Q9P0J0,Q9BUB7,Q8N183,O75380 9 |
| Map3k1 role in promoting and blocking gonadal determination 0.3647554259799163 0.6355491583525291 0.5250703163212269 1.0 0.7041277734628901 3 P28482,P35222 2 |
| Dna damage response only atm dependent 0.3788012576320771 0.6323399987352659 0.5271647320535413 1.0 0.7048741100534908 21 Q16822,Q13794,P31751,O00459,Q99570,P42771,P62993 7 |
| Endoplasmic reticulum stress response in coronavirus infection 0.4242380462817908 0.6215078974882166 0.5342654998939633 1.0 0.7127560055018789 5 P05198 1 |
| Dna irdamage and cellular response via atr 0.3601697791627629 0.603629383443905 0.5460900728028828 1.0 0.7236305673239994 34 Q9BXW9,Q9HAW4,Q92900,P53350,Q8WXE1,P43246,P06493,Q9NVI1,Q9UQ84,P46063 10 |
| Ras signaling 0.3724803990580714 0.595641085924825 0.5514150232071062 1.0 0.7280679297417952 21 P55196,P31751,O00459,P05771 4 |
| Amino acid metabolism 0.32134209525202 0.5920874789249309 0.5537920110116126 1.0 0.7289333597057083 53 O00330,Q16836,O75874,Q8TD30 4 |
| Gastric cancer network 2 0.4214153015460694 0.5886575526220453 0.5560910179165703 1.0 0.7303328701970958 13 Q14739,Q9HB71 2 |
| Angiopoietinlike protein 8 regulatory pathway 0.3618171786504214 0.5662009365820564 0.571257193332761 1.0 0.7452825634871121 24 P46108,P42345,P31751,Q99570,P13807,P54646,Q9UPT5,P41440 8 |
| Selenium micronutrient network 0.4189465094149436 0.5379802240687819 0.5905907015686682 1.0 0.7617072079251329 12 Q99707,Q13162,Q8WTV0,Q8NFF5 4 |
| Gastrin signaling pathway 0.3709608744771508 0.527223119564518 0.5980386554179218 1.0 0.7617072079251329 19 P46108,P42345,Q15717,O00459,P42771,P35222,P62993 7 |
| Folate metabolism 0.3932777242778842 0.5239532640024909 0.6003110466075046 1.0 0.7617072079251329 15 P41440,Q8NFF5,Q8WTV0,P13995 4 |
| Focal adhesion pi3kaktmtorsignaling pathway 0.3446791407446331 0.5235355444739928 0.6006016224925752 1.0 0.7617072079251329 36 P14625,P42345,P06756,P23588,P31751,O00459,Q99570,O14654,P13807,P54646,P30153,P30154,P62993 13 |
| 16p112 proximal deletion syndrome 0.3525619193245363 0.5156356918734167 0.60610887710139 1.0 0.7654067230062426 22 P30153,Q8TF05 2 |
| Nicotine effect on dopaminergic neurons 0.3674659753726507 0.4980678723469243 0.6184362042741987 1.0 0.777231157577699 4 P63096,P62136,Q00535 3 |
| Vitamin dsensitive calcium signaling in depression 0.4215932474687892 0.4846912161336225 0.6278953982670408 1.0 0.7845373792300657 7 Q8NB78,P48506 2 |
| Insulin signaling 0.3392383581234018 0.4778404407465515 0.6327637751226116 1.0 0.7889523018933828 35 P46108,P42345,P31751,P05771,P13807,P54646,P41440 7 |
| Physicochemical features and toxicityassociated pathways 0.4074008763174835 0.4561463060122522 0.6482847735456803 1.0 0.8032207571603711 11 P62993,P07197,P35222,P07196 4 |
| Thermogenesis 0.3376636981740365 0.4279336510170434 0.6686994265577675 1.0 0.8233361689492512 27 O43772,P50416,P23786,P42345 4 |
| Nucleotide excision repair in xeroderma pigmentosum 0.3349824350921462 0.4239283123001647 0.6716180954398838 1.0 0.8245435918269971 31 P41440,Q9NR33,P49005 3 |
| Lncrna in canonical wnt signaling and colorectal cancer 0.3830315528207899 0.4167580946982495 0.6768553566004867 1.0 0.8282018959645706 13 P61978,P48729 2 |
| Influence of laminopathies on wnt signaling 0.4010858790744945 0.40621903269803 0.6845816707814816 1.0 0.8359251393220157 7 P50402 1 |
| Ppar signaling pathway 0.3463002174327778 0.4014181614538147 0.6881122803014743 1.0 0.8367785136999409 19 P23786,Q08426,P50416,Q15067,Q13418,O15254,P48163 7 |
| Egfegfr signaling pathway 0.3263207192370945 0.3910636979506353 0.6957501530425432 1.0 0.8425990582953751 34 P41240,P46108,P42345,Q8IZP0,O00459,P05771,P46109,Q9P0J0,O14965 9 |
| Hair follicle development cytodifferentiation part 3 of 3 0.3126012309685747 0.3864151467223445 0.6991892341681276 1.0 0.8450323873074916 3 Q06330,P35222 2 |
| Prion disease pathway 0.3921505027570392 0.3735482460610588 0.7087404444171732 1.0 0.8548277605113253 7 P14625,P40763,P28482,Q9UQE7,P13591,O60216 6 |
| Energy metabolism 0.3890695527032788 0.3598451655270743 0.7189629252936727 1.0 0.8601358073857501 10 Q99873,Q13131,Q15648,P54646,Q13555 5 |
| Dna irdouble strand breaks and cellular response via atm 0.322641852170466 0.3471652488343071 0.728467176544769 1.0 0.864506227586262 26 Q9UQ84 1 |
| Ciliopathies 0.3545755202224826 0.3316409283749538 0.7401604106174571 1.0 0.8748696053498343 14 Q86Y56,Q99570,Q8WYA0,Q15555,Q10713,Q8TD19,Q93008 7 |
| Il3 signaling pathway 0.3780527778702113 0.3204711616802321 0.7486111881716169 1.0 0.8830922399389732 9 O00459,P46109 2 |
| Ethanol effects on histone modifications 0.3702903702941173 0.313082088635967 0.7542182967339524 1.0 0.8855546753617463 11 P41440,Q96KQ7,Q99707 3 |
| Type 2 papillary renal cell carcinoma 0.3755391577793533 0.311798275351509 0.7551938348262608 1.0 0.8855546753617463 9 Q92733 1 |
| Pyrimidine metabolism 0.3030921751001989 0.3002275708934478 0.7640035760170814 1.0 0.8879850350345653 39 P49005,Q9NR33,Q14181,Q07864,P04183,P31350,P17812,O15160 8 |
| Atm signaling pathway 0.3423132090181976 0.2992110880787142 0.7647789895644563 1.0 0.8879850350345653 15 Q9BXW9 1 |
| Mbdnf and probdnf regulation of gaba neurotransmission 0.3651102464332059 0.2848708651375649 0.7757430777937551 1.0 0.8940716330952297 6 P40763,O95782,O00459,P63010,O94973 5 |
| Acute viral myocarditis 0.3422499375045389 0.2583401935299437 0.7961443688120551 1.0 0.9083423204013988 13 Q13418,P78310 2 |
| Cysteine and methionine catabolism 0.3525701035788641 0.2460024182796412 0.8056803605028244 1.0 0.9156867174176332 6 P48506 1 |
| Rett syndrome causing genes 0.3253848854819853 0.2356732741630094 0.8136862099164814 1.0 0.9212424330663612 15 P46108,Q9BXF3 2 |
| Alpha 6 beta 4 signaling pathway 0.345138910309234 0.2172902416158779 0.8279821614936247 1.0 0.929069816166174 8 O00459,P42345 2 |
| Translation inhibitors in chronically activated pdgfra cells 0.3150683327338578 0.2131476273056339 0.8312118168637719 1.0 0.929069816166174 16 P42345,P23588,P31751,O00459,Q04637,Q14240 6 |
| Ebola virus infection in host 0.2892058837160624 0.2121596137591613 0.8319825130436007 1.0 0.929069816166174 37 P10321,Q96AX1,P05198,Q14315,P06756,O00459,P52294,P19525,P41440,P12814 10 |
| Retinoblastoma gene in cancer 0.2790819714775454 0.2069478892248796 0.8360505557797457 1.0 0.929069816166174 44 Q14527,Q9Y619 2 |
| Pparalpha pathway 0.3414054463875879 0.2066028458334511 0.8363200375641364 1.0 0.929069816166174 8 P23786,Q08426,P06493,P50416 4 |
| Small cell lung cancer 0.3355042610217326 0.1994814837135468 0.8418861261424779 1.0 0.9334985000941922 11 P31751,O00459,P06756 3 |
| Splicing factor nova regulated synaptic proteins 0.3103806808469294 0.1850166907936934 0.8532159442207872 1.0 0.940681280723906 15 Q9UBB6,Q9UNS2,O14936,Q9Y2J2,Q7Z460,Q13555 6 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.3223332376678945 0.1762124985134449 0.8601270020349534 1.0 0.9431342281602516 12 P50402 1 |
| Thyroid hormones production and peripheral downstream signaling effects 0.3172177921018209 0.1619172361531582 0.8713710294383756 1.0 0.950860831026892 12 P62993,P35222,P42345,P06756 4 |
| Measles virus infection 0.2785609370092318 0.1602695020892353 0.8726687821041377 1.0 0.950860831026892 23 P05198,Q7Z434,O00459,P19525,P11802 5 |
| Epithelial to mesenchymal transition in colorectal cancer 0.2842257752631646 0.147831888485953 0.8824754424577961 1.0 0.9544633907846164 19 P31751,O00459,Q16625,O60315,P62993 5 |
| Myometrial relaxation and contraction pathways 0.2938191833537856 0.1450154315494627 0.8846986879669037 1.0 0.9544633907846164 16 P10644 1 |
| Parkinsons disease pathway 0.3145647197029946 0.1446103717230378 0.8850185078679691 1.0 0.9544633907846164 6 Q9Y385 1 |
| Tca cycle in senescence 0.3103340007162455 0.1278189830092955 0.898292227019422 1.0 0.9589598217474676 8 P23368 1 |
| Vegfavegfr2 signaling pathway 0.2476149467837874 0.1224916757839038 0.9025096381121424 1.0 0.9589598217474676 160 P48735,Q9Y613,P09543,P06756,P24666,Q12800,O00459,Q16625,Q8N3C0,Q14157,P62993,P41240,P55209,Q9Y678,O15371,Q96J02,P62906,P55196,Q04637,Q8NBS9,O43852,Q12849,P05771,Q9Y305,Q15650,P11940,P46108,P28289,P42345,P05198,O60568,O60762,P54646,Q9HCE1,Q96KB5,P27797 36 |
| Apoptosis 0.3050641843149737 0.1198394441063573 0.9046103352082392 1.0 0.9589598217474676 11 Q13794,P42771 2 |
| Calcium regulation in cardiac cells 0.2623273098455956 0.1066624089571177 0.9150568057300827 1.0 0.9589598217474676 23 P05771,P10644,P27797,P04899 4 |
| Joubert syndrome 0.2777960289148644 0.1018960202176778 0.9188392089278996 1.0 0.9589598217474676 16 Q10713 1 |
| Sterol regulatory elementbinding proteins srebp signaling 0.2648031257854693 0.1007399709578494 0.9197568805208756 1.0 0.9589598217474676 32 Q8WTV0,P42345,Q9HCL2,P54646,Q9NUB1 5 |
| Hair follicle development organogenesis part 2 of 3 0.2514581983149783 0.1004119400141996 0.9200172909150796 1.0 0.9589598217474676 4 Q9BZE4,P35222,P13591 3 |
| Nanoparticlemediated activation of receptor signaling 0.2514581983149763 0.1004119400141951 0.9200172909150832 1.0 0.9589598217474676 4 Q9Y490,P28482,P62993 3 |
| 22q112 copy number variation syndrome 0.262265179138602 0.09291336478118 0.9259723881191138 1.0 0.962940594272304 30 Q96DF8,Q92973 2 |
| Wnt signaling 0.2724550696784658 0.0783581764748785 0.9375431415330052 1.0 0.9710439875540722 14 P48729 1 |
| Parkinubiquitin proteasomal system pathway 0.2571590949812522 0.0772109981005002 0.9384556925479884 1.0 0.9710439875540722 31 Q9Y385,O75832 2 |
| Nanomaterial induced apoptosis 0.258670988654788 0.0749069677168535 0.9402887326989005 1.0 0.9710439875540722 5 O43464,O95831,Q16611,P49327 4 |
| G13 signaling pathway 0.2700208793369504 0.0734235929910849 0.9414690437706994 1.0 0.9710439875540722 14 O00459,Q7L576 2 |
| Photodynamic therapyinduced unfolded protein response 0.282946773686702 0.0691121333680971 0.944900363092029 1.0 0.9711932427606768 10 P14625,P05198 2 |
| Epo receptor signaling 0.2476499189627282 0.0570458085560304 0.9545087045779876 1.0 0.9742912684034382 5 P62993,P40763,P42224,P28482 4 |
| Photodynamic therapyinduced ap1 survival signaling 0.2588387933830733 0.0418254219096971 0.9666378689884844 1.0 0.9782242818017026 7 P07900,P49327,P42771,P04637,Q07820,Q16611 6 |
| Prolactin signaling pathway 0.2461041417439367 0.0349659242114831 0.972106912788351 1.0 0.9787886376283316 15 O00459,P42345 2 |
| Effect of progerin on genes involved in hutchinsongilford progeria syndrome 0.2524366471734893 0.0322886210559122 0.9742418835566832 1.0 0.979041451339534 12 O60341,Q13330,Q92769,Q16576,P83916,Q14839,P45973,Q13547,P04637,Q13185,O94776 11 |
|
|
